United States Wound Care Management Market Outlook to 2025 – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT) and Others
Powered by
All the vital news, analysis, and commentary curated by our industry experts.

Published: August 30, 2020 Report Code: GDMEMC0571DB-ST
- Share on Twitter
- Share on LinkedIn
- Share on Facebook
- Share via Email
- Copy Link
GlobalData’s “United States Wound Care Management Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Wound Care Management market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT), Ostomy Drainage Bags, Oxygen Therapy Devices, Pressure Relief Devices, Surgical Sutures, Tissue Engineered – Skin Substitutes, Traditional Wound Management, Wound Closure Devices and Wound Debridement Devices.
The United States Wound Care Management Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for Wound Care Management Market.
• Global corporate-level profiles of key companies operating within the United States Wound Care Management Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United States Wound Care Management is segmented as follows:
• Advanced Wound Management
• Compression Therapy
• Negative Pressure Wound Therapy (NPWT)
• Ostomy Drainage Bags
• Oxygen Therapy Devices
• Pressure Relief Devices
• Surgical Sutures
• Tissue Engineered – Skin Substitutes
• Traditional Wound Management
• Wound Closure Devices
• Wound Debridement Devices
Reasons to Buy
Key Reasons to Purchase – The United States Wound Care Management Market report helps you to develop:
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
• Acelity Holdings, Inc. (Inactive)
• Smith & Nephew Plc
• Cardinal Health Inc
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 16
1.2 List of Figures 22
2 Introduction 25
2.1 What Is This Report About? 25
2.2 Wound Care Management Market Segmentation 25
2.3 Definitions of Markets Covered in the Report 29
3 Wound Care Management Market, United States 45
3.1 Wound Care Management Market, United States, Revenue ($m), 2015-2025 45
3.2 Wound Care Management Market, United States, Revenue Mix ($m), 2019 47
3.3 Wound Care Management Market, United States, Category Contribution by Revenue ($m), 2019 48
3.4 Wound Care Management Market, United States, Revenue ($m), 2015-2025 50
3.5 Wound Care Management Market, United States, Volume (Units), 2015-2025 53
3.6 Wound Care Management Market, United States, Volume (Units), 2015-2025 55
3.7 Wound Care Management Market, United States, Company Share by Revenue ($m), 2019 58
4 Advanced Wound Management Market, United States 60
4.1 Advanced Wound Management Market, United States, Revenue Mix ($m), 2019 60
4.2 Advanced Wound Management Market, United States, Segment Contribution (%), 2019 61
4.3 Advanced Wound Management Market, United States, Revenue ($m), 2015-2025 63
4.3.1 Alginates Market, United States, Revenue ($m), by Segment, 2015-2025 66
4.3.2 Collagens Market, United States, Revenue ($m), by Segment, 2015-2025 68
4.3.3 Foams Market, United States, Revenue ($m), by Segment, 2015-2025 70
4.3.4 Hydrocolloids Market, United States, Revenue ($m), by Segment, 2015-2025 72
4.3.5 Hydrofibres Market, United States, Revenue ($m), by Segment, 2015-2025 74
4.3.6 Hydrogels Market, United States, Revenue ($m), by Segment, 2015-2025 76
4.3.7 Semi-Permeable Films Market, United States, Revenue ($m), by Segment, 2015-2025 78
4.3.8 Superabsorbents Market, United States, Revenue ($m), by Segment, 2015-2025 80
4.3.9 Wound Contact Layers Market, United States, Revenue ($m), by Segment, 2015-2025 82
4.4 Advanced Wound Management Market, United States, Volume (Units), 2015-2025 84
4.4.1 Alginates Market, United States, Volume (Units), by Segment, 2015-2025 87
4.4.2 Collagens Market, United States, Volume (Units), by Segment, 2015-2025 89
4.4.3 Foams Market, United States, Volume (Units), by Segment, 2015-2025 91
4.4.4 Hydrocolloids Market, United States, Volume (Units), by Segment, 2015-2025 93
4.4.5 Hydrofibres Market, United States, Volume (Units), by Segment, 2015-2025 95
4.4.6 Hydrogels Market, United States, Volume (Units), by Segment, 2015-2025 97
4.4.7 Semi-Permeable Films Market, United States, Volume (Units), by Segment, 2015-2025 99
4.4.8 Superabsorbents Market, United States, Volume (Units), by Segment, 2015-2025 101
4.4.9 Wound Contact Layers Market, United States, Volume (Units), by Segment, 2015-2025 103
4.5 Advanced Wound Management Market, United States, Average Price ($) , 2015-2025 105
4.6 Advanced Wound Management Market, United States, Distribution Share by Revenue ($m), 2019 109
4.7 Advanced Wound Management Market, United States, Company Share by Revenue ($m), 2019 110
5 Compression Therapy Market, United States 113
5.1 Compression Therapy Market, United States, Revenue Mix ($m), 2019 113
5.2 Compression Therapy Market, United States, Segment Contribution (%), 2019 114
5.3 Compression Therapy Market, United States, Revenue ($m), 2015-2025 115
5.3.1 Pneumatic Compression Therapy Market, United States, Revenue ($m), by Segment, 2015-2025 117
5.3.2 Static Compression Therapy Market, United States, Revenue ($m), by Segment, 2015-2025 119
5.4 Compression Therapy Market, United States, Volume (Units), 2015-2025 121
5.4.1 Pneumatic Compression Therapy Market, United States, Volume (Units), by Segment, 2015-2025 123
5.4.2 Static Compression Therapy Market, United States, Volume (Units), by Segment, 2015-2025 125
5.5 Compression Therapy Market, United States, Average Price ($), 2015-2025 127
5.6 Compression Therapy Market, United States, Distribution Share by Revenue ($m), 2019 129
5.7 Compression Therapy Market, United States, Company Share by Revenue ($m), 2019 130
6 Negative Pressure Wound Therapy (NPWT) Market, United States 132
6.1 Negative Pressure Wound Therapy (NPWT) Market, United States, Revenue ($m), 2015-2025 132
6.1.1 NPWT Devices & Accessories Market, United States, Revenue ($m), by Segment, 2015-2025 134
6.2 Negative Pressure Wound Therapy (NPWT) Market, United States, Volume (Units), 2015-2025 136
6.2.1 NPWT Devices & Accessories Market, United States, Volume (Units), by Segment, 2015-2025 138
6.3 Negative Pressure Wound Therapy (NPWT) Market, United States, Average Price ($), 2015-2025 140
6.4 Negative Pressure Wound Therapy (NPWT) Market, United States, Distribution Share by Revenue ($m), 2019 141
6.5 Negative Pressure Wound Therapy (NPWT) Market, United States, Company Share by Revenue ($m), 2019 142
7 Ostomy Drainage Bags Market, United States 144
7.1 Ostomy Drainage Bags Market, United States, Revenue Mix ($m), 2019 144
7.2 Ostomy Drainage Bags Market, United States, Segment Contribution (%), 2019 145
7.3 Ostomy Drainage Bags Market, United States, Revenue ($m), 2015-2025 146
7.3.1 Colostomy Market, United States, Revenue ($m), by Segment, 2015-2025 148
7.3.2 Ileostomy Market, United States, Revenue ($m), by Segment, 2015-2025 150
7.3.3 Urostomy Market, United States, Revenue ($m), by Segment, 2015-2025 152
7.4 Ostomy Drainage Bags Market, United States, Volume (Units), 2015-2025 154
7.4.1 Colostomy Market, United States, Volume (Units), by Segment, 2015-2025 156
7.4.2 Ileostomy Market, United States, Volume (Units), by Segment, 2015-2025 158
7.4.3 Urostomy Market, United States, Volume (Units), by Segment, 2015-2025 160
7.5 Ostomy Drainage Bags Market, United States, Average Price ($), 2015-2025 162
7.6 Ostomy Drainage Bags Market, United States, Distribution Share by Revenue ($m), 2019 164
7.7 Ostomy Drainage Bags Market, United States, Company Share by Revenue ($m), 2019 165
8 Oxygen Therapy Devices Market, United States 166
8.1 Oxygen Therapy Devices Market, United States, Revenue ($m), 2015-2025 166
8.1.1 Hyperbaric Oxygen Chambers Market, United States, Revenue ($m), by Segment, 2015-2025 168
8.2 Oxygen Therapy Devices Market, United States, Volume (Units), 2015-2025 170
8.2.1 Hyperbaric Oxygen Chambers Market, United States, Volume (Units), by Segment, 2015-2025 172
8.3 Oxygen Therapy Devices Market, United States, Average Price ($) , 2015-2025 174
8.4 Oxygen Therapy Devices Market, United States, Distribution Share by Revenue ($m), 2019 175
8.5 Oxygen Therapy Devices Market, United States, Company Share by Revenue ($m), 2019 176
9 Pressure Relief Devices Market, United States 178
9.1 Pressure Relief Devices Market, United States, Revenue Mix ($m), 2019 178
9.2 Pressure Relief Devices Market, United States, Segment Contribution (%), 2019 179
9.3 Pressure Relief Devices Market, United States, Revenue ($m), 2015-2025 180
9.3.1 Mattress Overlays Market, United States, Revenue ($m), by Segment, 2015-2025 182
9.3.2 Mattresses Market, United States, Revenue ($m), by Segment, 2015-2025 184
9.4 Pressure Relief Devices Market, United States, Volume (Units), 2015-2025 186
9.4.1 Mattress Overlays Market, United States, Volume (Units), by Segment, 2015-2025 188
9.4.2 Mattresses Market, United States, Volume (Units), by Segment, 2015-2025 190
9.5 Pressure Relief Devices Market, United States, Average Price ($), 2015-2025 192
9.6 Pressure Relief Devices Market, United States, Distribution Share by Revenue ($m), 2019 194
9.7 Pressure Relief Devices Market, United States, Company Share by Revenue ($m), 2019 195
10 Surgical Sutures Market, United States 197
10.1 Surgical Sutures Market, United States, Revenue Mix ($m), 2019 197
10.2 Surgical Sutures Market, United States, Segment Contribution (%), 2019 198
10.3 Surgical Sutures Market, United States, Revenue ($m), 2015-2025 199
10.3.1 Automated Suturing Devices Market, United States, Revenue ($m), by Segment, 2015-2025 201
10.3.2 Sutures Market, United States, Revenue ($m), by Segment, 2015-2025 203
10.4 Surgical Sutures Market, United States, Volume (Units), 2015-2025 205
10.4.1 Automated Suturing Devices Market, United States, Volume (Units), by Segment, 2015-2025 207
10.4.2 Sutures Market, United States, Volume (Units), by Segment, 2015-2025 209
10.5 Surgical Sutures Market, United States, Average Price ($) , 2015-2025 211
10.6 Surgical Sutures Market, United States, Distribution Share by Revenue ($m), 2019 212
10.7 Surgical Sutures Market, United States, Company Share by Revenue ($m), 2019 213
11 Tissue Engineered – Skin Substitutes Market, United States 215
11.1 Tissue Engineered – Skin Substitutes Market, United States, Revenue Mix ($m), 2019 215
11.2 Tissue Engineered – Skin Substitutes Market, United States, Segment Contribution (%), 2019 216
11.3 Tissue Engineered – Skin Substitutes Market, United States, Revenue ($m), 2015-2025 217
11.3.1 Acellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2015-2025 219
11.3.2 Cellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2015-2025 221
11.4 Tissue Engineered – Skin Substitutes Market, United States, Volume (Units), 2015-2025 223
11.4.1 Acellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2015-2025 225
11.4.2 Cellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2015-2025 227
11.5 Tissue Engineered – Skin Substitutes Market, United States, Average Price ($), 2015-2025 229
11.6 Tissue Engineered – Skin Substitutes Market, United States, Distribution Share by Revenue ($m), 2019 230
11.7 Tissue Engineered – Skin Substitutes Market, United States, Company Share by Revenue ($m), 2019 231
12 Traditional Wound Management Market, United States 233
12.1 Traditional Wound Management Market, United States, Revenue Mix ($m), 2019 233
12.2 Traditional Wound Management Market, United States, Segment Contribution (%), 2019 234
12.3 Traditional Wound Management Market, United States, Revenue ($m), 2015-2025 235
12.3.1 Abdominal Pads (ABD) Market, United States, Revenue ($m), by Segment, 2015-2025 238
12.3.2 Bandages Market, United States, Revenue ($m), by Segment, 2015-2025 240
12.3.3 Gauze Sponges Market, United States, Revenue ($m), by Segment, 2015-2025 242
12.3.4 Gauzes Market, United States, Revenue ($m), by Segment, 2015-2025 244
12.3.5 Sponges Market, United States, Revenue ($m), by Segment, 2015-2025 246
12.4 Traditional Wound Management Market, United States, Volume (Units), 2015-2025 248
12.4.1 Abdominal Pads (ABD) Market, United States, Volume (Units), by Segment, 2015-2025 251
12.4.2 Bandages Market, United States, Volume (Units), by Segment, 2015-2025 253
12.4.3 Gauze Sponges Market, United States, Volume (Units), by Segment, 2015-2025 255
12.4.4 Gauzes Market, United States, Volume (Units), by Segment, 2015-2025 257
12.4.5 Sponges Market, United States, Volume (Units), by Segment, 2015-2025 259
12.5 Traditional Wound Management Market, United States, Average Price ($), 2015-2025 261
12.6 Traditional Wound Management Market, United States, Distribution Share by Revenue ($m), 2019 263
12.7 Traditional Wound Management Market, United States, Company Share by Revenue ($m), 2019 264
13 Wound Closure Devices Market, United States 266
13.1 Wound Closure Devices Market, United States, Revenue Mix ($m), 2019 266
13.2 Wound Closure Devices Market, United States, Segment Contribution (%), 2019 267
13.3 Wound Closure Devices Market, United States, Revenue ($m), 2015-2025 268
13.3.1 Ligating Clips Market, United States, Revenue ($m), by Segment, 2015-2025 271
13.3.2 Surgical Adhesion Barriers Market, United States, Revenue ($m), by Segment, 2015-2025 273
13.3.3 Tissue Adhesives Market, United States, Revenue ($m), by Segment, 2015-2025 275
13.3.4 Tissue Sealants Market, United States, Revenue ($m), by Segment, 2015-2025 277
13.3.5 Topical Absorbable Hemostats Market, United States, Revenue ($m), by Segment, 2015-2025 279
13.4 Wound Closure Devices Market, United States, Volume (Units), 2015-2025 282
13.4.1 Ligating Clips Market, United States, Volume (Units), by Segment, 2015-2025 285
13.4.2 Surgical Adhesion Barriers Market, United States, Volume (Units), by Segment, 2015-2025 287
13.4.3 Tissue Adhesives Market, United States, Volume (Units), by Segment, 2015-2025 289
13.4.4 Tissue Sealants Market, United States, Volume (Units), by Segment, 2015-2025 291
13.4.5 Topical Absorbable Hemostats Market, United States, Volume (Units), by Segment, 2015-2025 293
13.5 Wound Closure Devices Market, United States, Average Price ($) , 2015-2025 296
13.6 Wound Closure Devices Market, United States, Distribution Share by Revenue ($m), 2019 299
13.7 Wound Closure Devices Market, United States, Company Share by Revenue ($m), 2019 300
14 Wound Debridement Devices Market, United States 302
14.1 Wound Debridement Devices Market, United States, Revenue Mix ($m), 2019 302
14.2 Wound Debridement Devices Market, United States, Segment Contribution (%), 2019 303
14.3 Wound Debridement Devices Market, United States, Revenue ($m), 2015-2025 304
14.4 Wound Debridement Devices Market, United States, Volume (Units), 2015-2025 306
14.5 Wound Debridement Devices Market, United States, Average Price ($) , 2015-2025 308
14.6 Wound Debridement Devices Market, United States, Distribution Share by Revenue ($m), 2019 309
14.7 Wound Debridement Devices Market, United States, Company Share by Revenue ($m), 2019 310
15 Overview of Key Companies in United States, Wound Care Management Market 312
15.1 Acelity Holdings, Inc. (Inactive) 312
15.1.1 Company Overview 312
15.2 Smith & Nephew Plc 312
15.2.1 Company Overview 312
15.3 Cardinal Health Inc 312
15.3.1 Company Overview 312
15.4 Hollister Inc 312
15.4.1 Company Overview 312
15.5 Allergan Ltd 313
15.5.1 Company Overview 313
15.6 Hill-Rom Holdings Inc 313
15.6.1 Company Overview 313
15.7 Ethicon Inc 313
15.7.1 Company Overview 313
15.8 Medline Industries Inc 313
15.8.1 Company Overview 313
15.9 BSN medical GmbH 314
15.9.1 Company Overview 314
15.10 Molnlycke Health Care AB 314
15.10.1 Company Overview 314
15.11 ConvaTec Group Plc 314
15.11.1 Company Overview 314
15.12 Coloplast A/S 314
15.12.1 Company Overview 314
15.13 Derma Sciences Inc 315
15.13.1 Company Overview 315
15.14 CR Bard Inc 315
15.14.1 Company Overview 315
15.15 Organogenesis Inc 315
15.15.1 Company Overview 315
15.16 3M Co 315
15.16.1 Company Overview 315
15.17 Stryker Corp 316
15.17.1 Company Overview 316
15.18 Medtronic Plc 316
15.18.1 Company Overview 316
15.19 Integra LifeSciences Corp 316
15.19.1 Company Overview 316
15.20 ArjoHuntleigh AB 316
15.20.1 Company Overview 316
15.21 B. Braun Melsungen AG 317
15.21.1 Company Overview 317
15.22 Paul Hartmann AG 317
15.22.1 Company Overview 317
15.23 MiMedx Group Inc 317
15.23.1 Company Overview 317
15.24 Baxter International Inc 317
15.24.1 Company Overview 317
16 Wound Care Management Market Pipeline Products 318
17 Financial Deals Landscape 319
17.1 Acquisition 319
17.1.1 Safeguard Medical Acquires Water-Jel Technologies 319
17.1.2 Conventus Orthopaedics Acquires Flower Orthopedics 320
17.1.3 Conatus Pharma Acquires Histogen 321
17.1.4 Vivo Capital May Sell Surgical Specialties for USD500 Million 323
17.1.5 Amneal Pharma to Acquire
65.1% Stake in AvKARE 324
17.1.6 Novartis Acquires The Medicines Co 326
17.1.7 Dare Bioscience Acquires Microchips Biotech 329
17.1.8 Marmon Acquires 60% Stake in Colson Medical Companies from Colson Associates 331
17.1.9 Generex Biotech Acquires Additional 38% Stake in Olaregen Therapeutix 333
17.1.10 AtriCure to Acquire SentreHEART 334
17.1.11 Stedical Scientific Acquires PermeaDerm 336
17.2 Asset Transactions 337
17.2.1 SANUWAVE Health to Acquire UltraMIST and Exclusive Partnership Rights for Wound Care Biologic Products from Celularity 337
17.2.2 Mitsubishi Chemical Performance Polymers Acquires Assets from AdvanSource Biomaterials for USD7.3 Million 339
17.3 Debt Offerings 341
17.3.1 CryoLife Prices Private Placement of
4.250% Notes Due 2025 for USD100 Million 341
17.3.2 Arch Therapeutics Raises USD0.55 Million in Private Placement of Convertible Note 343
17.3.3 Stryker Raises USD650 Million in Public Offering of
1.15% Notes Due 2025 344
17.3.4 Stryker Raises USD1 Billion in Public Offering of
1.95% Notes Due 2030 346
17.3.5 Stryker Raises USD650 Million in Public Offering of
2.9% Notes Due 2050 348
17.3.6 Baxter International Raises USD500 Million in Private Placement of
3.95% Senior Notes Due 2030 350
17.3.7 Baxter International Raises USD750 Million in Private Placement of
3.75% Senior Notes Due 2025 351
17.3.8 Collegium Pharma Raises USD143.8 Million in Public Offering of
2.625% Notes Due 2026 352
17.3.9 Integra LifeSciences Prices Private Placement of
0.5% Convertible Senior Notes Due 2025 for USD500 Million 354
17.3.10 KitoTech Medical Raises USD1.5 Million in Private Placement of Bonds 356
17.3.11 Stryker Raises USD826.2 Million in Public Offering of 1% Notes Due 2031 357
17.3.12 Stryker Raises USD881.3 Million in Public Offering of
0.75% Notes Due 2029 359
17.3.13 Stryker Raises USD936.4 Million in Public Offering of
0.25% Notes Due 2024 361
17.3.14 Hill-Rom (Hillrom) to Raise USD425 Million in Private Placement of Notes 363
17.3.15 SweetBio Raises USD0.80 Million in Debt Offering 364
17.4 Equity Offerings 365
17.4.1 ACell to Raise up to USD80 Million in IPO of Shares 365
17.4.2 Innovation Pharma Files Registration Statement for Public Offering of Securities up to USD60 Million 367
17.4.3 Tenax Therapeutics to Raise USD8 Million in Private Placement of Shares 368
17.4.4 SINTX Technologies to Raise USD41.3 Million in Public offering of Shares 370
17.4.5 Avita Medical to Raise Funds in Public Offering of Shares 372
17.4.6 SINTX Technologies Prices Private Placement of Shares for USD5.6 Million 373
17.4.7 Arch Therapeutics to Raise USD0.85 Million in Private Placement upon Exercise of Warrants 374
17.4.8 ThermoGenesis to Raise USD15 Million in Public Offering of Common Stock 375
17.4.9 Lineage Cell Therapeutics Files Registered Statement for Public Offering of Securities up to USD75 Million 377
17.4.10 Lineage Cell Therapeutics Files Registered Statement for Public Offering of Securities up to USD25 Million 379
17.4.11 NovaBay Pharma to Raise USD4.3 Million in Public Offering of Shares 381
17.4.12 ThermoGenesis Holdings Raises USD3.5 Million in Registered Direct Offering 383
17.4.13 Collegium Pharma Plans to Raise up to USD15.6 Million in Public Offering of Shares 384
17.4.14 Harpoon Therapeutics Files Registration Statement for Public Offering of Securities for up to USD250 Million 385
17.4.15 Harpoon Therapeutics Plans to Raise USD75 Million in Public Offering of Shares 386
17.4.16 Tenax Therapeutics Prices Private Placement of Shares and Warrants for USD2.8 Million 387
17.4.17 PolarityTE Prices Public Offering of Shares and Warrants for USD25 Million 388
17.4.18 SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock 390
17.4.19 Synedgen Raises USD2.6 Million in Financing 391
17.4.20 Sintx Technologies to Raise USD8.8 million in Rights Offering 392
17.4.21 Misonix Prices Public Offering of Shares for USD30 Million 394
17.4.22 NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million 396
17.4.23 Orgenesis to Raise USD9.2 Million in Private Placement of Shares and Warrants 398
17.4.24 Abeona Therapeutics Raises USD103.5 Million in Public Offering of Shares and Warrants 400
17.4.25 ThermoGenesis Files Registration Statement for Public Offering of Shares for up to USD30 Million 402
17.4.26 Sonoma Pharma Raises USD1.6 Million in Public Offering of Shares 403
17.4.27 Arch Therapeutics Plans to Raise Funds through Public Offering of Shares 404
17.4.28 Organogenesis Prices USD45 Million Public Offering of Shares 405
17.4.29 Avita Medical Raises USD15.4 Million in Private Placement of Shares 407
17.4.30 Collegium Pharma Plans to Raise up to USD300 Million in Public Offering of Securities 408
17.4.31 PolarityTE Plans to Raise up to USD21.8 Million in Public Offering of Shares 409
17.4.32 Arch Therapeutics Raises USD2.5 Million in Private Placement of Units 410
17.4.33 Sanara MedTech Raises USD10 Million in Private Placement of Shares 412
17.4.34 Drive DeVilbiss Healthcare Raises USD35 Million in Financing Round 413
17.4.35 BIOLIFE4D to Raise up to USD47.6 Million in Public Offering of Shares 414
17.4.36 Organogenesis Plans to Raise up to USD100 Million in Public Offering of Securities 415
17.4.37 NovaBay Pharma Raises USD4.2 Million in Registered Direct Offering of Shares 416
17.4.38 NovaBay Pharma Raises USD2.7 Million in Private Placement of Preferred Stock and Warrants 418
17.5 Grants 420
17.5.1 Novel Polymer Matrix for Dental Applications 420
17.6 Merger 421
17.6.1 Organovo Holdings Terminates Merger with Tarveda Therapeutics 421
17.6.2 Organovo Holdings Receives Merger Proposal from Viscient Biosciences 423
17.7 Partnerships 424
17.7.1 Rochal Industries Enters into Licensing Agreement with Sanara MedTech 424
17.7.2 BandGrip Enters into Agreement with Medline Industries 425
17.7.3 CryoLife Enters into Agreement with Misonix 426
17.7.4 Mayo Clinic and W. L. Gore & Associates Form Joint Venture 427
17.7.5 Avita Medical Enters into Licensing Agreement with University of Colorado Anschutz Medical Campus 428
17.7.6 Rochal Industries Enters into Licensing Agreement with Sanara MedTech 429
17.7.7 BioCardia Enters into Development Agreement with AstraZeneca 430
17.8 Private Equity 431
17.8.1 MiMedx to Raise USD100 Million in Private Equity Financing 431
17.8.2 Lattice Biologics to Raise USD4.24 Million in Private Placement of Shares 433
17.8.3 PolarityTE to Raise up to USD25 Million in Private Financing 434
17.8.4 Corre Partners and Legion Partners Invests USD100 Million in NN 436
17.8.5 BioRestorative Therapies to Raise USD5.4 Million in Private Financing 437
17.9 Venture Financing 438
17.9.1 Zurex Pharma Raises USD7.5 Million in Venture Financing 438
17.9.2 Imbed Biosciences Raises USD1.5 Million in Venture Financing 439
17.9.3 R2 Technologies Raises USD10 Million in Second Tranche of Series B Financing 440
17.9.4 Poly Group Raises USD0.1 Million in Venture Financing 441
17.9.5 Vaporox Raises USD1.5 Million in Financing 442
17.9.6 Biostage Raises USD2.18 Million in Venture Financing 443
17.9.7 Surgimatix to Raise USD1 Million in Venture Financing 444
17.9.8 Akeso Biomedical Raises USD0.6 Million in Venture Financing 445
17.9.9 Turn Therapeutics Raises Funds through Series B Financing 446
17.9.10 Carmell Therapeutics Raises USD0.1 Million in Venture Financing 447
17.9.11 Recovery Force Health Raises USD10 Million in Venture Financing 448
17.9.12 Gemstone Biotherapeutics Raises USD0.25 Million in Financing Round 449
17.9.13 Dezzio (GoRelax) Secures USD0.15 Million in Crowdfunding 450
17.9.14 Electrochemical Oxygen Concepts Raises USD2.3 Million in Venture Financing 451
17.9.15 Omeza Secures Additional USD1.25 Million in Venture Funding 452
17.9.16 Aatru Medical Raises Funds through Venture Financing 453
17.9.17 Nevoa Life Sciences Raises USD1.6 Million in Venture Financing 454
18 Recent Developments 455
18.1 Corporate Communications 455
18.1.1 Jul 09, 2020: Abeona Therapeutics announces appointment of Michael Amoroso as Chief Commercial Officer 455
18.1.2 Mar 23, 2020: McKesson announces executive vice president and chief strategy and business development officer to step down 455
18.1.3 Mar 02, 2020: Stryker announces new Investor Relations leader 456
18.1.4 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum 456
18.1.5 Feb 22, 2020: Amniox appoints new vice president of Sales 456
18.1.6 Feb 21, 2020: Tenax announces the addition of Mayo Clinic expert, Dr. Barry Borlaug, to Scientific Advisory Board 457
18.1.7 Feb 20, 2020: Agenus announces positive interim data from a study of AGEN1181 457
18.1.8 Feb 18, 2020: NN appoints Warren Veltman as president and CEO 458
18.1.9 Feb 16, 2020: CEO of Mako Medical announced the launch of new nutritional DNA test 458
18.1.10 Feb 14, 2020: CollPlant Biotechnologies raising $4.45 million in U.S. Private Placement 459
18.1.11 Feb 13, 2020: DERMALOG provides the world’s first biometric border control system with integrated fever detection 459
18.1.12 Feb 10, 2020: Chi-Med highlights updated phase II Savolitinib / Imfinzi combination data in advanced papillary renal cell carcinoma at 2020 ASCO Genitourinary Cancers Symposium 460
18.1.13 Feb 10, 2020: Collegium Pharmaceutical announces Proposed Convertible Senior Notes Offering 461
18.1.14 Feb 06, 2020: Henry Ford Health System announces new president and CEO Of Health Alliance Plan 462
18.1.15 Feb 04, 2020: Henry Ford Medical Group names new Chair of Board of Governors 463
18.1.16 Jan 28, 2020: 3M Company: Departure of directors or certain officers 463
18.1.17 Jan 27, 2020: Yamaha Motor Ventures & Laboratory Silicon Valley leads seed funding round for Australian Health Technology Startup loop+ 464
18.1.18 Jan 24, 2020: Cardinal Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers 464
18.1.19 Jan 20, 2020: Innovative Healthcare provider INLIV recruits industry veteran Lori Casselman to Scale Wello as President and Chief Revenue Officer 464
18.1.20 Jan 16, 2020: Audax Private Debt provides financing to support Olympus Partners Investment in Soliant Health 465
18.1.21 Jan 13, 2020: Orgenesis appoints industry veteran Mario Philips to its board of directors 465
18.1.22 Jan 08, 2020: BioCardia announces new U.S. patent covering CardiAMP cell therapy and issuance of two Asian patents covering Radial Artery approach for Cardiac Cell and Gene Therapy Delivery 465
18.1.23 Jan 08, 2020: Midatech Pharma: Positive results from MTD201-102 study support subcutaneous route for long-acting octreotide product 466
18.1.24 Jan 08, 2020: Anavex Life Sciences issued new U.S. patent for ANAVEX2-73 treatment of Neurodevelopmental Disorders including Rett Syndrome and Multiple Sclerosis 468
18.1.25 Jan 07, 2020: Abeona Therapeutics: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers 468
18.1.26 Jan 02, 2020: ThermoGenesis Holdings announces board of directors and management changes 469
18.1.27 Dec 31, 2019: NN hires Christina Carroll and Tom Wilson to board of directors 469
18.1.28 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 470
18.1.29 Dec 20, 2019: Hill-Rom Holdings nominates Felicia Norwood to stand for election to its board of directors 470
18.1.30 Dec 20, 2019: Hill-Rom Holdings nominates Felicia Norwood to stand for election to its board of directors 471
18.1.31 Dec 19, 2019: World-Renowned Neurosurgeon selected to lead nationally-recognized Henry Ford Medical Group 471
18.1.32 Dec 19, 2019: Dynatronics welcomes new general counsel and senior director of sales operations 472
18.1.33 Dec 19, 2019: Innovation Pharmaceuticals: Departure of Directors or Certain Officers; Election of Directors 472
18.1.34 Dec 18, 2019: Owens & Minor names David Myers as SVP & Chief Procurement Officer 473
18.1.35 Dec 16, 2019: MiMedx Announces addition of Peter M. Carlson 473
18.1.36 Dec 16, 2019: Jean-Claude Dubacher named Chairman and Chief Executive Officer of B. Braun Medical 473
18.1.37 Dec 09, 2019: Michael C. Riordan Elected to Owens & Minor board of directors 474
18.1.38 Dec 09, 2019: McKesson appoints Nancy Flores as executive vice president, chief information and chief technology officer 474
18.1.39 Dec 06, 2019: Gilero opens new design center in Southern California 475
18.1.40 Dec 05, 2019: Orthofix names Kevin Kenny president of global spine business 475
18.1.41 Dec 05, 2019: Johnson & Johnson names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors 475
18.1.42 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 476
18.1.43 Nov 27, 2019: Luna Innovations names Gene Nestro as Chief Financial Officer 477
18.1.44 Nov 26, 2019: Dr. Emanual Maverakis, recipient of presidential award for scientists and engineers, joins RenovaCare 477
18.1.45 Nov 26, 2019: MiMedx names William “Butch” Hulse as General Counsel and Secretary 478
18.1.46 Nov 18, 2019: RenovaCare appoints Alan L. Rubino as President and CEO 479
18.1.47 Nov 13, 2019: Bausch + Lomb And TerraCycle announce donation of new custom training modules incorporating used contact lens Materials to Guide Dog Foundation 480
18.1.48 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 481
18.1.49 Nov 06, 2019: Owens & Minor announces new organizational structure to better serve customers 481
18.1.50 Nov 05, 2019: Stereotaxis and inHEART combine robotic precision and advanced preoperative 3D mapping to treat cardiac arrhythmias 482
18.1.51 Nov 01, 2019: Orthofix appoints Jon Serbousek as President and Chief Executive Officer 483
18.1.52 Oct 31, 2019: Orgenesis appoints Bala S. Manian to its scientific advisory board 483
18.1.53 Oct 23, 2019: Arlington capital partners portfolio company Riverpoint Medical names Doug King as chief executive officer 484
18.1.54 Oct 18, 2019: McKesson’s Board of Directors appoints Maria Martinez as new independent Director 484
18.1.55 Oct 14, 2019: Anika appoints Mira Leiwant as vice president of regulatory affairs, quality, and clinical affairs 485
18.1.56 Oct 10, 2019: Atrium Health welcomes new Senior Vice President, Enterprise Strategy and Planning 485
18.1.57 Oct 10, 2019: Jefferson Hospital earns prestigious perinatal care certification from Joint Commission 486
18.1.58 Oct 08, 2019: BioDerm adds CFO and new board member to strengthen the management team and enhance growth prospects 487
18.1.59 Oct 07, 2019: Xtant Medical names Sean Browne President and Chief Executive Officer 487
18.1.60 Oct 01, 2019: Owens & Minor appoints Robert Henkel to its board of directors 488
18.1.61 Oct 01, 2019: Sonoma Pharmaceuticals announces Management Changes 488
18.1.62 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 489
18.1.63 Sep 24, 2019: Dr. Frank Gerberick, Procter & Gamble product safety veteran, joins RenovaCare 489
18.1.64 Sep 23, 2019: CONMED adds LaVerne Council and Barbara Schwarzentraub to its Board of Directors 490
18.1.65 Sep 20, 2019: MiMedx announces resignation of board member 491
18.1.66 Sep 19, 2019: Vivex Biologics announces Peter Wehrly as the new CEO of the company 491
18.1.67 Sep 18, 2019: Invacare appoints Julie Beck to Board of Directors 491
18.1.68 Sep 16, 2019: NovaBay Pharmaceuticals names Finance Executive Jeff Zheng to its Board of Directors 492
18.1.69 Sep 16, 2019: BioRestorative Therapies scientific advisory board member and clinical director of regenerative disc/spine program, Dr. Wayne J. Olan, to receive prestigious award 492
18.1.70 Sep 13, 2019: FDA clears GE’s AI algorithms to identify pneumothorax 493
18.1.71 Sep 06, 2019: Cytokinetics to present on its Hypertrophic Cardiomyopathy drug candidate CK-274 at 23rd Annual HFSA Scientific Meeting 494
18.1.72 Sep 06, 2019: United Health Products appoints Dr. Gerard Abate Chief Medical Director 494
18.1.73 Sep 05, 2019: Mary Beth Vitale appointed to Luna Innovations board of directors 495
18.1.74 Sep 04, 2019: PolarityTE appoints Peter Cohen as Chairman of the Board 495
18.1.75 Sep 03, 2019: MemorialCare Long Beach Medical Center names Eric Ramos, M.D., FAAFP, as new Chief Medical Officer 496
18.1.76 Aug 28, 2019: Rose Kelly-Falls named global leader of procurement and supply chain for Cook Medical 496
18.1.77 Aug 28, 2019: Dynatronics promotes Brian Baker to Chief Executive Officer 497
18.1.78 Aug 26, 2019: GT Medical Technologies to be honored with an AZBio Fast Lane Award 497
18.1.79 Aug 26, 2019: PolarityTE: Changes in board 499
18.1.80 Aug 20, 2019: Dr. Robin Robinson, founding director of BARDA joins RenovaCare 499
18.1.81 Aug 19, 2019: Merit Medical announces appointment of Lynne N. Ward to its Board of Directors 500
18.1.82 Aug 16, 2019: Edwards SAPIEN 3 TAVR receives FDA approval for Low-Risk Patients 500
18.1.83 Aug 12, 2019: Stryker announces commercial structure realignment 501
18.1.84 Aug 07, 2019: Mark A. Beck elected to Owens & Minor Board of Directors 501
18.1.85 Aug 07, 2019: Dean Scarborough and John Weiland to join Cardinal Health’s Board of Directors 502
18.1.86 Aug 05, 2019: SFA Therapeutics requests FDA orphan drug designation (ODD) for SFA001 for treatment of hepatocellular carcinoma (HCC) 503
18.1.87 Aug 05, 2019: Orthofix names Jon Serbousek to Succeed CEO 503
18.1.88 Jul 25, 2019: Owens & Minor expands Senior Leadership team to Accelerate Company Growth 504
18.1.89 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 505
18.1.90 Jul 24, 2019: AirXpanders announces board changes 505
18.1.91 Jul 22, 2019: Adynxx adds Gregory J. Flesher to board of directors, completes up-listing to OTCQB market 506
18.1.92 Jul 22, 2019: Tactile Medical appoints Jay Stracke as Vice President of Reimbursement and Payer Relations 506
18.1.93 Jul 22, 2019: Owens & Minor names Mark Zacur as SVP, Chief Procurement Officer 507
18.1.94 Jul 16, 2019: BioDerm’s President Gaet Tyranski to assume President and Chief Executive Officer Responsibilities 507
18.1.95 Jul 16, 2019: Cardinal Health appoints Stephen Mason to lead medical segment 508
18.2 Financial Announcements 508
18.2.1 May 06, 2020: Abeona Therapeutics reports first quarter financial results and business updates 508
18.2.2 May 06, 2020: Harpoon Therapeutics reports first quarter 2020 financial results and provides corporate update 509
18.2.3 May 01, 2020: Hillrom’s fiscal second quarter financial results exceed guidance 510
18.2.4 Mar 16, 2020: Abeona Therapeutics reports fourth quarter and full year 2019 financial results and business updates 513
18.2.5 Mar 12, 2020: Lineage Cell Therapeutics reports fourth quarter and full year 2019 financial results and provides business update 513
18.2.6 Mar 09, 2020: Organogenesis Holdings reports fourth quarter and fiscal year 2019 financial results; Introduces fiscal year 2020 revenue guidance 516
18.2.7 Mar 03, 2020: GenSight Biologics announces presentation of bilateral visual recovery from GS010 (LUMEVOQ) Phase III trials at the 46th annual meeting of NANOS 519
18.2.8 Feb 28, 2020: Lattice Biologics reports Q1 2020 results 521
18.2.9 Feb 27, 2020: Collegium reports full-year 2019 revenue of $296.7 million 522
18.2.10 Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance 523
18.2.11 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance 524
18.2.12 Feb 14, 2020: Sonoma Pharmaceuticals reports third quarter FY 2020 financial results 525
18.2.13 Feb 13, 2020: CryoLife reports fourth quarter and full year 2019 financial results 526
18.2.14 Feb 10, 2020: Invacare announces financial results for the fourth quarter and full year ended December 31, 2019 527
18.2.15 Feb 06, 2020: Cardinal Health reports second quarter results for fiscal year 2020 529
18.2.16 Feb 04, 2020: McKesson reports fiscal 2020 third quarter results 530
18.2.17 Jan 29, 2020: Avery Dennison announces fourth quarter and full year 2019 results 531
18.2.18 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook 532
18.2.19 Jan 22, 2020: Johnson & Johnson reports 2019 fourth-quarter and full year results 533
18.2.20 Jan 17, 2020: Scandinavian ChemoTech receives its first order from their new distributor in India 534
18.2.21 Jan 15, 2020: SomaLogic adds three new SomaSignal tests to its current offerings 535
18.2.22 Jan 13, 2020: Organogenesis Holdings reports preliminary revenue results for the fourth quarter and fiscal year 2019 536
18.2.23 Jan 13, 2020: Emergent BioSolutions announces preliminary 2019 financial results and provides 2020 financial forecast 537
18.2.24 Jan 13, 2020: Misonix reports preliminary fiscal 2020 second quarter revenue of approximately $19.7 million 538
18.2.25 Jan 13, 2020: Tactile Systems Technology reports preliminary full year and fourth quarter 2019 revenue results 539
18.2.26 Jan 12, 2020: Baxter announces preliminary net sales for the fourth-quarter and full-year 2019 and announces preliminary full-year 2020 guidance 540
18.2.27 Dec 31, 2019: Belgium customers select C-RAD’s innovative SIGRT solution 541
18.2.28 Dec 19, 2019: REDBUD LABS STR microfluidic chip enables 1000x faster sample prep for on-cartridge magnetic bead assay 542
18.2.29 Dec 18, 2019: Terason partners with AmCad BioMed to provide more efficient solutions to assess and diagnose obstructive sleep apnea 543
18.2.30 Dec 05, 2019: Epic Sciences to present new data showing feasibility of its liquid biopsy test in breast cancer 545
18.2.31 Dec 01, 2019: Hyland Healthcare launches new products and updates at RSNA 2019 547
18.2.32 Nov 20, 2019: UM trial to study new Stent that treated life-threatening brain aneurysm 549
18.2.33 Nov 19, 2019: ThermoGenesis Holdings announces improved third quarter 2019 financial results and provides corporate update 551
18.2.34 Nov 18, 2019: Sintx technologies releases 2019 third quarter and year to date earnings report and provides business update 553
18.2.35 Nov 15, 2019: SANUWAVE health reports third quarter 2019 financial results 553
18.2.36 Nov 14, 2019: Sonoma Pharmaceuticals reports second quarter FY 2020 financial results 555
18.2.37 Nov 13, 2019: AdaptHealth Corp. announces third quarter 2019 financial results for its AdaptHealth Holdings LLC subsidiary 556
18.2.38 Nov 12, 2019: Biostage reports third quarter 2019 financial results 557
18.2.39 Nov 12, 2019: Lineage Cell Therapeutics reports third quarter 2019 financial results and provides business update 558
18.2.40 Nov 12, 2019: Abeona Therapeutics reports third quarter 2019 financial results and business updates 560
18.2.41 Nov 12, 2019: PolarityTE reports third calendar quarter 2019 results 561
18.2.42 Nov 12, 2019: Organogenesis Holdings reports third quarter and nine months of 2019 financial results 562
18.2.43 Nov 12, 2019: Dynatronics reports first quarter results for fiscal 2020 565
18.2.44 Nov 08, 2019: Orgenesis third quarter 2019 revenue increases 46% to a record $9.1 Million 565
18.2.45 Nov 07, 2019: Cardinal Health reports first quarter results for fiscal year 2020 566
18.2.46 Nov 07, 2019: InnerWorkings reports Q3 2019 financial results 567
18.2.47 Nov 07, 2019: NovaBay Pharmaceuticals reports 2019 third quarter financial results 567
18.2.48 Nov 07, 2019: Xtant Medical announces third quarter 2019 financial results 568
18.2.49 Nov 06, 2019: Scandit integrates with Epic Rover to enable accurate native iOS camera scanning in healthcare 569
18.2.50 Nov 06, 2019: Owens & Minor reports 3rd quarter 2019 financial results 570
18.2.51 Nov 06, 2019: Invacare reports results for third quarter 2019 570
18.2.52 Nov 06, 2019: Collegium reports third quarter 2019 financial results 572
18.2.53 Nov 06, 2019: Emergent BioSolutions reports financial results for third quarter and nine months ended September 30, 2019 573
18.2.54 Nov 06, 2019: Harpoon Therapeutics reports third quarter 2019 financial results and provides corporate update 575
18.2.55 Nov 05, 2019: Luna Innovations reports strong third-quarter 2019 results 576
18.2.56 Nov 04, 2019: Tactile Systems Technology reports third quarter 2019 financial results; updates 2019 outlook 577
18.2.57 Oct 30, 2019: Cue Biopharma announces upcoming scientific presentation at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting 579
18.2.58 Oct 30, 2019: McKesson reports fiscal 2020 second-quarter results 581
18.2.59 Oct 30, 2019: The Medicines Company reports third-quarter 2019 financial results and achievement of major milestones for inclisiran 582
18.2.60 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 583
18.2.61 Oct 30, 2019: CONMED announces third quarter 2019 financial results 583
18.2.62 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 584
18.2.63 Oct 28, 2019: Orthofix reports third quarter 2019 results 586
18.2.64 Oct 24, 2019: Integra LifeSciences reports third quarter 2019 financial results 587
18.2.65 Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results 587
18.2.66 Oct 24, 2019: Anika reports third quarter 2019 financial results 589
18.2.67 Oct 15, 2019: Johnson & Johnson reports 2019 Third-Quarter Results 590
18.2.68 Sep 28, 2019: GRAIL to present new data in late-breaking oral presentation at the European Society for Medical Oncology (ESMO) 2019 Congress 591
18.2.69 Sep 28, 2019: Orchestra BioMed announces late-breaking clinical results showing BackBeat Cardiac Neuromodulation Therapy drives significant reduction in systolic blood pressure 593
18.2.70 Sep 25, 2019: Dynatronics reports fourth quarter and full year results for fiscal 2019 595
18.2.71 Sep 19, 2019: Tresiba showed an overall lower risk of Hypoglycaemia and significantly lower HbA1c when compared to Insulin Glargine U300 in people with Type 2 Diabetes 596
18.2.72 Aug 29, 2019: Philips debuts innovations in ultrasound and enterprise informatics to advance cardiac care at ESC 2019 597
18.2.73 Aug 29, 2019: Lattice Biologics reports third quarter 2019 results 598
18.2.74 Aug 28, 2019: Approval for the additional formulation of Samsca OD tablets in Japan 599
18.2.75 Aug 27, 2019: Gold nanoparticles shown to be safe and effective treatment for prostate cancer 600
18.2.76 Aug 21, 2019: aap receives US-American clearance (FDA) for polyaxial LOQTEQ VA calcaneus system; market launch planned for beginning of 2020 602
18.2.77 Aug 15, 2019: SANUWAVE Health reports second quarter 2019 financial results 603
18.2.78 Aug 14, 2019: Coloplast delivers 8% organic growth and solid performance across all business areas 604
18.2.79 Aug 14, 2019: Coloplast announcement no. 07/2019 – 9M interim financial report, 2018/19 605
18.2.80 Aug 14, 2019: Misonix reports fourth quarter and fiscal year 2019 results 605
18.2.81 Aug 13, 2019: Biostage reports second quarter 2019 financial results 607
18.2.82 Aug 13, 2019: Cesca Therapeutics announces improved second quarter 2019 financial results and provides corporate update 608
18.2.83 Aug 13, 2019: Sonoma pharmaceuticals reports first quarter FY 2020 financial results 609
18.2.84 Aug 12, 2019: Applied Therapeutics reports second quarter 2019 financial results 610
18.2.85 Aug 12, 2019: Orgenesis second quarter 2019 revenue increases 95% to a record $7.8 Million 611
18.2.86 Aug 09, 2019: Abeona Therapeutics reports second quarter 2019 financial results and business updates 612
18.2.87 Aug 09, 2019: Organogenesis Holdings reports second quarter and first half 2019 financial results 612
18.2.88 Aug 08, 2019: Xtant Medical announces second quarter 2019 financial results 615
18.2.89 Aug 08, 2019: NN releases Q2 2019 financial results 615
18.2.90 Aug 08, 2019: Cardinal Health reports fourth quarter and full year results for fiscal year 2019 616
18.2.91 Aug 08, 2019: PolarityTE reports second calendar quarter 2019 results 618
18.2.92 Aug 08, 2019: BioTime reports second quarter 2019 financial results and provides business update 619
18.2.93 Aug 07, 2019: Collegium reports second quarter 2019 financial results 621
18.2.94 Aug 07, 2019: Owens & Minor reports 2nd quarter 2019 financial results 623
18.2.95 Aug 07, 2019: NovaBay Pharmaceuticals reports 2019 second quarter financial results 624
18.2.96 Aug 05, 2019: Tactile Systems Technology reports second quarter 2019 financial results; updates 2019 outlook 625
18.2.97 Aug 05, 2019: Orthofix reports second quarter 2019 results 627
18.2.98 Aug 05, 2019: Harpoon Therapeutics reports second quarter 2019 financial results and provides corporate update 627
18.2.99 Aug 05, 2019: Invacare reports results for second quarter 2019 628
18.2.100 Aug 02, 2019: Hillrom reports fiscal third quarter financial results 631
18.2.101 Aug 01, 2019: KIYATEC Assay hits the mark in study to predict patient response to first line ovarian cancer drugs 632
18.2.102 Jul 31, 2019: CONMED announces second quarter 2019 financial results 633
18.2.103 Jul 30, 2019: CryoLife reports second quarter 2019 financial results 634
18.2.104 Jul 25, 2019: Baxter reports second-quarter 2019 results 634
18.2.105 Jul 25, 2019: Merit Medical reports earnings for second quarter of 2019 636
18.2.106 Jul 25, 2019: Stryker reports second quarter 2019 operating results 638
18.2.107 Jul 24, 2019: Integra LifeSciences reports second quarter 2019 financial results 638
18.2.108 Jul 24, 2019: Anika reports second quarter 2019 financial results 639
18.2.109 Jul 22, 2019: Study investigates the ability of continuous noninvasive hemoglobin monitoring with Masimo SpHb to reflect acute hemodilution during incremental fluid administration 640
18.2.110 Jul 16, 2019: Johnson & Johnson reports 2019 Second-Quarter Results 642
18.3 Government and Public Interest 643
18.3.1 Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard 643
18.3.2 Sep 16, 2019: NAWCO announces first Advanced Wound Care Certified (AWCC) Clinicians 643
18.3.3 Sep 05, 2019: Invacare provides business update at Baird Global Healthcare Conference 643
18.3.4 Jul 24, 2019: Using body heat to speed healing 644
18.3.5 Jul 19, 2019: Reclassification of surgical staplers 645
18.4 Legal And Regulatory 645
18.4.1 Apr 08, 2020: PolarityTE announces conclusion of SEC investigation 645
18.4.2 Apr 06, 2020: MiMedx Group agrees to pay $6.5 million to resolve false claims act allegations of false commercial pricing disclosures 646
18.4.3 Jan 13, 2020: Cortexyme announces the initiation of an open-label extension study for the GAIN Trial of COR388 in Alzheimer’s disease 646
18.4.4 Jan 09, 2020: Pomerantz law firm investigates claims on behalf of investors of Baxter 647
18.4.5 Dec 19, 2019: gel-e changes its name to Medcura 647
18.4.6 Dec 16, 2019: Bausch Health Resolves “Stock Drop” Litigation initially filed in October 2015 648
18.4.7 Dec 03, 2019: Ferris Mfg. Corp. is pleased to announce settlement with an unauthorized distributor of its medical products 648
18.4.8 Dec 02, 2019: Rosen, a highly ranked firm, announces filing of securities class action lawsuit against Baxter International 649
18.4.9 Nov 26, 2019: MiMedx announces Securities and Exchange Commission Settlement 649
18.4.10 Nov 26, 2019: SEC charges biotech company and executives with accounting fraud 649
18.4.11 Nov 14, 2019: Agile Therapeutics announces FDA extension of Twirla NDA review period 650
18.4.12 Nov 06, 2019: Calmare Therapeutics has $842,000 judgment vacated by the U.S. Court Of Appeals for the second circuit 650
18.4.13 Nov 01, 2019: New innovations in technology could benefit veterans with PTSD 651
18.4.14 Oct 31, 2019: Cesca Therapeutics to change name and ticker symbol to reflect new strategic focus 652
18.4.15 Oct 30, 2019: SANUWAVE successfully completes extensive round of quality system and technical file audits 653
18.4.16 Oct 17, 2019: United Health products to move manufacturing to U.S. 653
18.4.17 Oct 08, 2019: Intralink-Spine receives ISO-13485 certification 654
18.4.18 Oct 08, 2019: United Health Products files defamation lawsuit against short sellers 654
18.4.19 Sep 30, 2019: Adocia announces receipt of USD
14.3 million payment from Eli Lilly following arbitration conclusion and the decision by mutual consent with Eli Lilly to conclude the civil case 655
18.4.20 Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker 655
18.4.21 Sep 04, 2019: LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 in Cardinal Health to contact the firm 655
18.4.22 Aug 29, 2019: Won Industry receives warning letter from FDA 655
18.4.23 Aug 23, 2019: Adocia announces that the American Arbitration Association Tribunal Dismissed all Claims in Second Phase of Arbitration With Eli Lilly 656
18.4.24 Aug 12, 2019: Lineage Cell Therapeutics launches new corporate brand 657
18.4.25 Aug 12, 2019: Lead plaintiff deadline alert: Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 In Cardinal Health to contact the firm 657
18.5 Other Significant Developments 658
18.5.1 Jul 10, 2020: NYU Langone Health expands ambulatory care network on Long Island 658
18.5.2 Jul 02, 2020: Osteopore signs initial U.S. distribution agreement 658
18.5.3 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education 659
18.5.4 Jun 24, 2020: Apria Healthcare celebrates 25 years of patient service and commitment to quality care 659
18.5.5 May 06, 2020: Markman Biologics will revolutionize the wound care domain 660
18.5.6 Apr 16, 2020: GEMCORE adapts wound dressing to help protect healthcare workers from friction injuries caused by personal protective equipment and donates 8,000 units 660
18.5.7 Apr 08, 2020: Anika takes actions to strengthen liquidity in light of covid-19 661
18.5.8 Apr 02, 2020: Organovo Holdings founder calls on board of directors to accept stockholders’ opposition to the illogical merger with Tarveda Therapeutics 661
18.5.9 Mar 31, 2020: Aroa Biosurgery opens new pathway for advanced wound treatment amidst covid-19 disruption in the United States 662
18.5.10 Mar 11, 2020: AllStar Health Brands announces it has entered into a distribution agreement With MedPharma Invest (Berberex) for the sales & marketing of patented wound care hospital and specialty skin care products 662
18.5.11 Feb 24, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan notes 663
18.5.12 Feb 11, 2020: InfuSystem enters negative pressure wound therapy market 663
18.5.13 Jan 30, 2020: Hollister awarded National, ASCEND Agreements in Ostomy Products with Premier 663
18.5.14 Jan 27, 2020: Breg adds benefits and eligibility checks to Breg Vision software for orthopedic bracing programs 664
18.5.15 Jan 23, 2020: Johnson & Johnson announces $250 million commitment to support Frontline Health Workers, reaching 100 million people by 2030 664
18.5.16 Jan 13, 2020: Healthpeak announces lease with Johnson & Johnson Subsidiary at The Shore at Sierra Point 665
18.5.17 Jan 13, 2020: Journey Medical recaps 2019 Growth 665
18.5.18 Jan 07, 2020: Nuvo Pharmaceuticals announces repayment of bridge loan and entitlement to receive 2019 Vimovo U.S. Annual minimum royalty 666
18.5.19 Jan 07, 2020: Collegium provides 2020 Financial Guidance 666
18.5.20 Jan 02, 2020: Lineage Cell Therapeutics conducts sale of shares in oncocyte 667
18.5.21 Dec 23, 2019: Orgenesis announces receipt of the $6.6 million second milestone payment into Masthercell Global subsidiary 667
18.5.22 Dec 20, 2019: Cook Medical applauds congressional action to repeal the medical device excise tax 668
18.5.23 Dec 20, 2019: United Health products issues progress report 668
18.5.24 Dec 12, 2019: McKesson selected by Department of Veterans Affairs as prime pharmaceutical provider 669
18.5.25 Dec 11, 2019: Innovation Hub provides funding to seven entrepreneurial teams 669
18.5.26 Nov 26, 2019: Kane Biotech engages Kilmer Lucas for cross-border Investor Relations 671
18.5.27 Nov 14, 2019: BioMarin announces cumulative additional height gain of
9.0 cm over 54 months versus natural history in children with Achondroplasia treated with Vosoritide in phase 2 study 672
18.5.28 Nov 04, 2019: Ernie Green Industries and Gilero announce business realignment 674
18.5.29 Oct 29, 2019: Dissolution of a wholly-owned subsidiary–Clearbridge Health USA 674
18.5.30 Oct 16, 2019: Orgenesis announces Co-Development Agreement with Accellix 674
18.5.31 Oct 14, 2019: UH Rainbow Babies & Children’s Hospital receives $3 million to establish Pediatric Disaster Care Center of Excellence 675
18.5.32 Oct 07, 2019: Misuse of Surgical Staplers Tops ECRI Institute’s 2020 Technology Hazards List 675
18.5.33 Sep 24, 2019: Axxess partners with Swift Medical to enhance wound care offerings and help home health clients thrive under PDGM 676
18.5.34 Sep 16, 2019: BIOLIFE4D modifies its regulation A+ (Mini-IPO) offering following significant scientific achievement 676
18.5.35 Sep 13, 2019: BioRestorative Therapies comments on recent promotional activity 677
18.5.36 Sep 11, 2019: Bio-Tissue Expands National Footprint, Ramps Up Sales Force by More than 25 Percent 678
18.5.37 Sep 09, 2019: Cesca Therapeutics and ThermoGenesis announce major global distribution agreement for the company’s X-Series products 679
18.5.38 Sep 03, 2019: Abeona Therapeutics announces strategic review 679
18.5.39 Aug 21, 2019: Joerns Healthcare completes reorganization plans 680
18.5.40 Jul 29, 2019: SINTX Technologies provides business update 680
18.5.41 Jul 29, 2019: Innovation Pharmaceuticals provides corporate update highlighting clinical pipeline progress and business development activities 681
18.5.42 Jul 29, 2019: NovaBay Pharmaceuticals reports 2019 second quarter net sales of $1.8 million 682
18.5.43 Jul 26, 2019: Court confirms reorganization plan for Joerns Healthcare 683
18.6 Product News 683
18.6.1 Jun 17, 2020: Researchers develop microscopy technique for noninvasive evaluation of wound healing 683
18.6.2 Feb 18, 2020: InventHelp inventor develops salve for treatment of burns (NWO-318) 684
18.6.3 Jan 13, 2020: InventHelp inventor develops therapeutic device for feet 684
18.6.4 Dec 20, 2019: Karolinska Development´s portfolio company Umecrine Cognition announces Notice of Allowance from USPTO for a patent protecting lead compound golexanolone 684
18.6.5 Dec 02, 2019: NanoVibronix to present at two investor conferences in December 685
18.6.6 Nov 05, 2019: Scapa Healthcare announces proprietary release system design for adhesive patches and dressings 685
18.6.7 Nov 01, 2019: Living skin can now be 3D-printed with blood vessels included 685
18.6.8 Oct 07, 2019: Arch Therapeutics provides corporate update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY 686
18.6.9 Oct 04, 2019: MEI Pharma announces updated clinical data from ME-401 phase 1b study in patients with Indolent B-cell Malignancies 687
18.6.10 Oct 04, 2019: McKesson launches strategic planning solution for community-based oncology customers 688
18.6.11 Sep 16, 2019: TeVido BioDevices announces availability of TruPigment for use in restoring lost skin color 689
18.6.12 Aug 14, 2019: Dynatronics to attend The National by FCA 2019 689
18.6.13 Aug 06, 2019: Endomedix to present its innovative technology addressing the needs of warfighters at the upcoming Military Health System and Research Symposium 2019 annual meeting 689
18.6.14 Jul 31, 2019: Ethicon: International experts convene to respond to the critical state of surgical site infections in Asia Pacific 690
18.6.15 Jul 25, 2019: Soft micro-monitors keep tabs on oxygen in new tissues 690
18.7 Research And Development 691
18.7.1 Nov 15, 2019: Invent Medic launches Efemia bladder support in Norway together with the distributor Quintet 691
18.7.2 Oct 23, 2019: BioRestorative Therapies receives a second patent in Australia for its metabolic program 692
18.8 Strategy And Business Planning 693
18.8.1 Jul 01, 2020: RenovaCare launches R&D innovation center (Berlin) for organ & tissue regeneration 693
18.8.2 Apr 14, 2020: Groundbreaking coalition of industry leaders bring telehealth to wound care at no cost during coronavirus pandemic 694
18.8.3 Apr 08, 2020: Sharp Fluidics buys robotic port closure technology from neoSurgical 694
18.8.4 Mar 11, 2020: RenovaCare announces new corporate headquarters and laboratory facilities 695
18.8.5 Jan 28, 2020: BandGrip Hooks the surgical suites of Rush University Medical Center with its advanced wound closure technology 695
18.8.6 Jan 21, 2020: Quartz and Advocate Aurora Health announce plans to collaborate in Eastern Wisconsin 696
18.8.7 Jan 16, 2020: New Bloomfield Township Medical Center: Enhancing the care experience 696
18.8.8 Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees 697
18.8.9 Jan 09, 2020: Zai Lab and Novocure announce first patient enrolled in a phase 2 pilot trial of tumor treating fields together with chemotherapy as first-line treatment of gastric cancer 698
18.8.10 Dec 13, 2019: 3M to divest drug delivery business to Altaris Capital in $650m deal 698
18.8.11 Dec 11, 2019: Amneal Pharmaceuticals to buy majority stake in AvKARE for $340m 699
18.8.12 Dec 06, 2019: Gilero opens new design center in Southern California 699
18.8.13 Nov 05, 2019: Stryker signs agreement to acquire Wright Medical for $5.4bn 700
18.8.14 Nov 05, 2019: Floyd Health System and Atrium Health to join in strategic combination 700
18.8.15 Nov 04, 2019: Atrium Health and Wake Forest one step closer to creating unique and transformative Academic Healthcare System 700
18.8.16 Oct 31, 2019: Continued expansion of gel-e’s consumer products label 702
18.8.17 Oct 15, 2019: Sanofi opens digital manufacturing facility in the US 702
18.8.18 Oct 02, 2019: Hollister announces grand opening of new manufacturing facility in Kaunas, Lithuania 703
18.8.19 Aug 30, 2019: Brigham Health announces September opening of comprehensive care facility in Pembroke 703
18.8.20 Aug 01, 2019: SeaSpine announces the launch of the Shoreline RT Cervical Interbody Implant System, featuring Reef Topography 704
19 Appendix 705
19.1 Research Methodology 706
19.1.1 Coverage 706
19.1.2 Secondary Research 706
19.1.3 Primary Research 707
19.1.4 Market Modeling and Forecasting 708
19.1.5 Company Share Analysis 709
19.1.6 Distribution Share Analysis 710
19.1.7 Benchmarking 710
19.2 GlobalData Consulting 710
19.3 Contact Us 711
19.4 Disclaimer 711
Frequently asked questions

- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.







Business Intelligence & Marketing Manager, SAL Heavy Lift“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab ABYour daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal FoodsHaving used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard CharteredOur experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYSGlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.
Related reports
View more Wound Care Management reportsEvery Company Report we produce is powered by the GlobalData Intelligence Center.
Subscribing to our intelligence platform means you can monitor developments at United States Wound Care Management Market Outlook to 2025 – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT) and Others in real time.
- Access a live United States Wound Care Management Market Outlook to 2025 – Advanced Wound Management, Compression Therapy, Negative Pressure Wound Therapy (NPWT) and Others dashboard for 12 months, with up-to-the-minute insights.
- Fuel your decision making with real-time deal coverage and media activity.
- Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.